References
- Wahyuningsih R, Adawiyah R, Sjam R, Prihartono J, Ayu Tri Wulandari E, Rozaliyani A, et al. Serious fungal disease incidence and prevalence in Indonesia. Mycoses. 2021;64(10): 1203–1212. doi:10.1111/myc.13304
- Shah A, James DA, Chotirmall SH. Respiratory mycoses: a call to action to recognize, educate and invest. Mycopathologia. 2021;186(5): 569–573. doi:10.1007/s11046-021-00589-3
- Rozaliyani A, Jusuf A, Priyanti ZA, Burhan E, Handayani D, Widowati H, et al. Infeksi jamur paru di Indonesia: Situasi saat ini dan tantangan di masa depan. Jurnal Respirologi Indonesia. 2019;39(3): 210–214. doi:10.36497/jri.v39i3.69
- Li Z, Lu G, Meng G. Pathogenic fungal infection in the lung. Frontiers in Immunology. 2019;10(1): 1–20. doi:10.3389/fimmu.2019.01524
- Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, et al. Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 2020;71(6): 1367–1376. doi:10.1093/cid/ciz1008
- Shin SH, Kim BG, Kang J, Um SW, Kim H, Kim HK, et al. Incidence and risk factors of chronic pulmonary aspergillosis development during long-term follow-up after lung cancer surgery. Journal of Fungi (Basel, Switzerland). 2020;6(4): 1–10. doi:10.3390/jof6040271
- Park S, Park S, Choi H, Park JY, Lim HS, Park MJ, et al. Invasive pulmonary aspergillosis in a patient with metastatic non-small cell lung cancer after treatment with gefitinib. The Korean Journal of Internal Medicine. 2018;33(1): 211–213. doi:10.3904/kjim.2015.276
- Larkin PMK, Multani A, Beaird OE, Dayo AJ, Fishbein GA, Yang S. A collaborative tale of diagnosing and treating chronic pulmonary aspergillosis, from the perspectives of clinical microbiologists, surgical pathologists, and infectious disease clinicians. Journal of Fungi (Basel, Switzerland). 2020;6(3): 1–27. doi:10.3390/jof6030106
- Prasenohadi, Hermansyah E, Rozaliyani A, Nurwidya F. Profile of fungal culture from bronchoalveolar lavage (BAL) and bronchial washing in bronchoscopy patients at Persahabatan Hospital, Jakarta. Pakistan Journal of Chest Medicine. 2021;27(2): 60–67.
- Vergidis P, Moore CB, Novak-Frazer L, Rautemaa-Richardson R, Walker A, Denning DW, et al. High-volume culture and quantitative real-time PCR for the detection of Aspergillus in sputum. Clinical Microbiology and Infection. 2020;26(7): 935–940. doi:10.1016/j.cmi.2019.11.019
- Electronic Data Process Arifin Achmad General Hospital. Data of the fungal culture on lung cancer patients during the period 2021–2023 at Arifin Achmad General Hospital. Pekanbaru, Riau: 2024.
- Vaezi A, Fakhim H, Ilkit M, Faeli L, Fakhar M, Alinejad V, et al. Rapid and low-cost culture-based method for diagnosis of mucormycosis using a mouse model. Frontiers in Microbiology. 2020;11: 440. doi:10.3389/fmicb.2020.00440
- Chen WY, Zhong C, Zhou JY, Zhou H. False positive detection of serum cryptococcal antigens due to insufficient sample dilution: a case series. World Journal of Clinical Cases. 2023;11(8): 1837–1846. doi:10.12998/wjcc.v11.i8.1837
- Pradnyaandara IGBMA, Saputra H, Dewi IGASM, Sumadi IWJ. Karakteristik pasien karsinoma paru di RSUP Sanglah Denpasar tahun 2017–2018. E-Jurnal Medika Udayana. 2021;10(8): 81–85. doi:10.24843/mu.2021.v10.i8.p13
- Alfarisa S, Mitra E, Wahyuni S. Karakteristik pasien kanker paru di RSUP Dr. M. Djamil Padang tahun 2021. Scientific Journal. 2023;2(6): 247–255. doi:10.56260/sciena.v2i6.116
- Hamaker ME, Oosterlaan F, van Huis LH, Thielen N, Vondeling A, van den Bos F. Nutritional status and interventions for patients with cancer: a systematic review. Journal of Geriatric Oncology. 2021;12(1): 6–21. doi:10.1016/j.jgo.2020.06.020
- Neto LCBS, Enriquez-Martinez OG, Grippa WR, Marcarini JAC, Santos TB, Mawandji NB, et al. Nutritional status of patients with neoplasms undergoing ambulatory chemotherapy and associated factors. Nutrients. 2025;17(1): 1–13. doi:10.3390/nu17010168
- Arends J, Muscaritoli M, Anker S, Audisio R, Barazzoni R, Bosnjak S, et al. Overcoming barriers to timely recognition and treatment of cancer cachexia: sharing progress in Cancer Care Task Force position paper and call to action. Critical Reviews in Oncology/Hematology. 2023;185: 103965. doi:10.1016/j. critrevonc.2023.103965
- Peng W, Li B, Li J, Chang L, Bai J, Yi Y, et al. Clinical and genomic features of Chinese lung cancer patients with germline mutations. Nature Communications. 2022;13(1): 1268. doi:10.1038/s41467–022-28840-5
- Alqarihi A, Kontoyiannis DP, Ibrahim AS. Mucormycosis in 2023: an update on pathogenesis and management. Frontiers in Cellular and Infection Microbiology. 2023;13: 1254919. doi:10.3389/fcimb.2023.1254919
- Forder A, Zhuang R, Souza VGP, Brockley LJ, Pewarchuk ME, Telkar N, et al. Mechanisms contributing to the comorbidity of COPD and lung cancer. International Journal of Molecular Sciences. 2023;24(3): 2859. doi:10.3390/ijms24032859
- Woldhuis RR, de Vries M, Timens W, van den Berge M, Demaria M, Oliver BGG, et al. Link between increased cellular senescence and extracellular matrix changes in COPD. American Journal of Physiology. Lung Cellular and Molecular Physiology. 2020;319(1): L48–L60. doi:10.1152/ajplung.00028.2020
- El-Badrawy MK, Elsaied AR, Ibrahim AAM, Eladl AE, Elmorsey RA. Prevalence and pattern of isolated fungi from bronchoalveolar lavage among patients with lung cancer: a prospective cross-sectional study. The Egyptian Journal of Bronchology. 2023;17: 7. doi:10.1186/s43168-023-00178-6
- Gupta P, Canonico ME, Faaborg-Andersen C, Prabhu N, Kondapalli L, Quintana RA. Updates in the management of cancer therapy-related hypertension. Current Opinion in Cardiology. 2024;39(4): 235–243. doi:10.1097/HCO.0000000000001127
- Akata K, van Eeden SF. Lung macrophage functional properties in chronic obstructive pulmonary disease. International Journal of Molecular Sciences. 2020;21(3): 853. doi:10.3390/ijms21030853
- Lu C, Mao X. Risk of adverse reactions associated with inhaled corticosteroids for chronic obstructive pulmonary disease: a meta-analysis. Medicine. 2024;103(3): e36609. doi:10.1097/MD.0000000000036609
- Rønberg R, Davidsen JR, Salzer HJF, Van Braeckel E, Rosenvinge FS, Laursen CB. Prevalence of chronic pulmonary aspergillosis in patients suspected of chest malignancy. Journal of Fungi (Basel, Switzerland). 2022;8(3): 297. doi:10.3390/jof8030297
- Zhang I, Pletcher SD, Goldberg AN, Barker BM, Cope EK. Fungal microbiota in chronic airway inflammatory disease and emerging relationships with the host immune response. Frontiers in Microbiology. 2017;8: 2477. doi:10.3389/fmicb.2017.02477
- Ayçiçek O, Pehlivanlar Küçük M, Koç İ, Ayaydin Mürtezaoğlu S, Pehlivanlar A, Öztuna F, et al. Fungal culture results and clinical effects of bronchoscopy specimens. Tuberkuloz Ve Toraks. 2022;70(1): 15–26. doi:10.5578/tt.20229903
- Laroumagne S, Lepage B, Hermant C, Plat G, Phelippeau M, Bigay-Game L, et al. Bronchial colonisation in patients with lung cancer: a prospective study. European Respiratory Journal. 2013;42(1): 220–229. doi:10.1183/09031936.00062212
- Harada G, Yang SR, Cocco E, Drilon A. Rare molecular subtypes of lung cancer. Nature Reviews Clinical Oncology. 2023;20(4): 229–249. doi:10.1038/s41571-023-00733-6
- Yao K, Qiu X, Hu H, Han Y, Zhang W, Xia R, et al. Pulmonary cryptococcosis coexisting with central type lung cancer in an immunocompetent patient: a case report and literature review. BMC Pulmonary Medicine. 2020;20(1): 161. doi:10.1186/s12890-020-01200-z
- Sayed ESR, Zaki AG, Ahmed AS, Ismaiel AA. Production of the anticancer drug taxol by the endophytic fungus Epicoccum nigrum TXB502: enhanced production by gamma irradiation mutagenesis and immobilization technique. Applied Microbiology and Biotechnology. 2020;104(16): 6991–7003. doi:10.1007/s00253-020-10712-x
- Nugratama KA, Raharjo AF, Mashuri YA. Risk factors for pulmonary mycosis in immunocompromised patients in Surakarta, Indonesia. Smart Medical Journal. 2024;7(1): 20. doi:10.13057/smj.v7i1.78386
- Nuh A, Ramadan N, Shah A, Armstrong-James D. Sputum galactomannan has utility in the diagnosis of chronic pulmonary aspergillosis. Journal of Fungi (Basel, Switzerland). 2022;8(2): 1–10. doi:10.3390/jof8020188
- Freeman Weiss Z, Leon A, Koo S. The evolving landscape of fungal diagnostics, current and emerging microbiological approaches. Journal of Fungi (Basel, Switzerland). 2021;7(2): 127. doi:10.3390/jof7020127
- Prakash P, Agarwal P, Gupta A, Gupta E, Dasgupta A. Comparison of induced sputum and bronchoalveolar lavage fluid examination in the diagnosis of sputum negative pulmonary tuberculosis. The Indian Journal of Chest Diseases and Allied Sciences. 2016;58(3): 173–175.
- Sahara SA, Ruliatna EF. The differences of Candida sp. colonization profiles in the sputum of lung cancer and pulmonary tuberculosis patients. Journal of Clinical Microbiology and Infectious Diseases. 2021;1(2): 46–52. doi:10.51559/jcmid.v1i2.10
- Azim A, Ahmed A. Diagnosis and management of invasive fungal diseases in non-neutropenic ICU patients, with focus on candidiasis and aspergillosis: a comprehensive review. Frontiers in Cellular and Infection Microbiology. 2024;14: 1256158. doi:10.3389/fcimb.2024.1256158
- Denning DW. Global incidence and mortality of severe fungal disease. The Lancet Infectious Diseases. 2024;24(7): e428–e438. doi:10.1016/S1473-3099(23)00692-8
- Barac A, Vujovic A, Drazic A, Stevanovic G, Paglietti B, Lukic K, et al. Diagnosis of chronic pulmonary aspergillosis: clinical, radiological or laboratory? Journal of Fungi (Basel, Switzerland). 2023;9(11): 1089. doi:10.3390/jof9111084c
- Zhang D, Li X, Zhang J, Wu J, Sun X. Characteristics of invasive pulmonary fungal diseases diagnosed by pathological examination. The Canadian Journal of Infectious Diseases and Medical Microbiology. 2021;2021(1): 3–6. doi:10.1155/2021/5944518
- Lamoth F, Calandra T. Pulmonary aspergillosis: diagnosis and treatment. European Respiratory Review. 2022;31(166): 1–15. doi:10.1183/16000617.0114-2022
- Kausar Z, Gupta S, Sharma A. Outcome of sputum fungal culture in clinically suspected cases of pulmonary aspergillosis. International Journal of Scientific Research. 2024;13(9): 16–18. doi:10.36106/ijsr/7206216
- Simatupang ETM, Indriani SI, Anggraini D, Yovi I, Aksa Fauzi Z, Simbolon RL. Sensitivity and specificity of fungal cultures from bronchial washing, bronchoalveolar lavage and tissue samples in patients with lung infections: a systematic review. African Journal of Biomedical Research. 2025;28(2): 783-791. doi:10.53555/AJBR.v28i2S.6541
- Garner W, Samanta P, Haidar G. Invasive fungal infections after anti-CD19 chimeric antigen receptor-modified T-cell therapy: state of the evidence and future directions. Journal of Fungi (Basel, Switzerland). 2021;7(2): 156. doi:10.3390/jof7020156
- Power M, Fell G, Wright M. Principles for high-quality, high-value testing. Evidence-Based Medicine. 2013;18(1): 5–10. doi:10.1136/eb-2012-100645
- Denning DW, Cadranel J, Beigelman-Aubry C, Ader F, Chakrabarti A, Blot S, et al. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management. European Respiratory Journal. 2016;47(1): 45–68. doi:10.1183/13993003.00583-2015
- Kontoyiannis DP, Reddy BT, Torres HA, Luna M, Lewis RE, Tarrand J, et al. Pulmonary candidiasis in patients with cancer: an autopsy study. Clinical Infectious Diseases. 2022;34(3): 400–403. doi:10.1086/338404
- Lin J, Feng B, Tang H, Xu H, Tang Y. A systematic review and meta-analysis: pulmonary mycosis pathogen distribution. Annals of Palliative Medicine. 2021;10(7): 7919–7932. doi:10.21037/apm-21-1388